Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ribosome Profiling02:24

Ribosome Profiling

3.9K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.4K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Tumor Progression02:07

Tumor Progression

7.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China.

The Lancet regional health. Western Pacific·2021
Same author

Lactone radical transformed methyl mercaptan-adsorbed activated carbon into graphene oxide modified activated carbon.

Journal of hazardous materials·2021
Same author

Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice.

Circulation research·2021
Same author

ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.

Aging·2021
Same author

The Effect of Reviewers' Self-Disclosure of Personal Review Record on Consumer Purchase Decisions: An ERPs Investigation.

Frontiers in psychology·2021
Same author

<i>In Situ</i> EBSD Study on the Microstructural Transformation of the Ni5W Substrate for Coated Conductors.

Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·2021
Same journal

Correction to "Mathematical Modelling of COVID-19 Transmission in Kenya: A Model with Reinfection Transmission Mechanism".

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Ligustrazine Inhibits Lung Phosphodiesterase Activity in a Rat Model of Allergic Asthma.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Delivery of miR-224-5p by Exosomes from Cancer-Associated Fibroblasts Potentiates Progression of Clear Cell Renal Cell Carcinoma.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Empirical Analysis of the Nursing Effect of Intelligent Medical Internet of Things in Postoperative Osteoarthritis.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Evaluation and Analysis of the Intervention Effect of Systematic Parent Training Based on Computational Intelligence on Child Autism.

Computational and mathematical methods in medicine·2024
Same journal

RETRACTION: Humanistic Spirit Training of Medical Students Based on Multisource Medical Data Fusion.

Computational and mathematical methods in medicine·2024
See all related articles

Related Experiment Video

Updated: Dec 5, 2025

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics
07:43

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Published on: May 3, 2024

4.0K

Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma.

Junfeng Chen1, Xiaojun Guo1, Guangjun Zeng1

  • 1Department of Orthopedics, Tianmen First People's Hospital, Tianmen, Hubei 431700, China.

Computational and Mathematical Methods in Medicine
|October 21, 2020
PubMed
Summary
This summary is machine-generated.

This study identifies five key genes (CD180, MYC, PROSER2, DNAI1, FATE1) to predict osteosarcoma (OS) patient survival. The developed risk model effectively stratifies patients, aiding in targeted therapy development for this aggressive bone cancer.

More Related Videos

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
05:27

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

2.0K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.5K

Related Experiment Videos

Last Updated: Dec 5, 2025

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics
07:43

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Published on: May 3, 2024

4.0K
Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
05:27

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

2.0K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.5K

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Osteosarcoma (OS) is a highly aggressive bone cancer primarily affecting young adults.
  • Predicting prognosis in OS patients is challenging due to small sample sizes and limited public datasets.
  • Advancements in high-throughput technologies enable the identification of prognostic biomarkers for cancer survival.

Purpose of the Study:

  • To identify novel prognostic gene expression biomarkers for osteosarcoma (OS) survival prediction.
  • To develop and validate a robust prognostic risk model for OS patients using gene expression data.
  • To explore the biological functions associated with different risk groups in OS.

Main Methods:

  • Utilized RNA-sequencing data from 82 OS samples from the TARGET database.
  • Employed random forest models to rank candidate prognostic genes.
  • Developed an optimal multivariable Cox regression model with five key predictors: CD180, MYC, PROSER2, DNAI1, and FATE1.
  • Created a scoring method for patient risk stratification and validated the model's performance.

Main Results:

  • Identified a five-gene signature (CD180, MYC, PROSER2, DNAI1, FATE1) as an optimal prognostic model for OS.
  • The developed risk model demonstrated robust performance in stratifying OS patients.
  • Differentially expressed genes between risk groups were significantly associated with immune-related biological pathways and processes.

Conclusions:

  • The identified five-gene signature serves as a novel prognostic biomarker for predicting OS patient survival.
  • The developed risk model can aid in stratifying patients and guiding the development of molecularly targeted therapies.
  • These findings contribute to improving patient outcomes and survival in osteosarcoma.